These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1279110)

  • 1. Hepatitis C viraemia rebound after "successful" interferon therapy in patients with chronic non-A, non-B hepatitis.
    Garson JA; Brillanti S; Ring C; Perini P; Miglioli M; Barbara L
    J Med Virol; 1992 Jul; 37(3):210-4. PubMed ID: 1279110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study.
    Brillanti S; Garson JA; Tuke PW; Ring C; Briggs M; Masci C; Miglioli M; Barbara L; Tedder RS
    J Med Virol; 1991 Jun; 34(2):136-41. PubMed ID: 1716296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Rebound" phenomenon of hepatitis C viremia after interferon therapy in "relapsed" patients with chronic hepatitis C.
    Hanada H; Hino K; Fujii K; Okazaki M; Okita K
    J Gastroenterol; 1995 Jun; 30(3):347-50. PubMed ID: 7544188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNA.
    Watanabe S; Kobayashi Y; Konishi M; Yokoi M; Kakehashi R; Kaito M; Suzuki S
    Intern Med; 1993 Jul; 32(7):523-9. PubMed ID: 8286827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
    Kakumu S; Yoshika K; Tanaka K; Higashi Y; Kurokawa S; Hirofuji H; Kusakabe A
    J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.
    Lau JY; Davis GL; Kniffen J; Qian KP; Urdea MS; Chan CS; Mizokami M; Neuwald PD; Wilber JC
    Lancet; 1993 Jun; 341(8859):1501-4. PubMed ID: 8099380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dynamic study of viraemia in chronic hepatitis C infection.
    Meng ZD; Sun YD; Sun DG; Liu CY; Copland J; Gowans EJ
    J Gastroenterol Hepatol; 1994; 9(3):242-4. PubMed ID: 7519895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment.
    Weiland O; Zhang YY; Widell A
    Scand J Infect Dis; 1993; 25(1):25-30. PubMed ID: 8384732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
    Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
    Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon.
    Ounanian A; Gueddah N; Rolachon A; Thelu MA; Zarski JP; Seigneurin JM
    J Med Virol; 1995 Feb; 45(2):141-5. PubMed ID: 7775931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.
    Shiratori Y; Kato N; Yoshida H; Imazeki F; Okano K; Yokosuka O; Omata M
    J Gastroenterol Hepatol; 1999 Jan; 14(1):79-84. PubMed ID: 10029282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of two high doses of lymphoblastoid interferon in the treatment of chronic hepatitis C: influence on the levels of ALT, viraemia and histologic activity.
    Enríquez J; Torras X; Miralles F; Martinez Cerezo FJ; Sancho Poch FJ; Buenestado J; Madoz P; Howe I; Vilardell F
    J Viral Hepat; 1995; 2(4):181-7. PubMed ID: 7489345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interferon-alpha on serum hepatitis C virus in patients with chronic hepatitis C.
    Shibata M; Kumada T; Yamada M; Nakano S; Kudo T; Morishima T
    Dig Dis Sci; 1993 Apr; 38(4):608-11. PubMed ID: 8384979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial density analysis of hepatitis C virus particle populations in chronic hepatitis C patients treated with interferon-alpha.
    Kanto T; Hayashi N; Takehara T; Hagiwara H; Mita E; Oshita M; Katayama K; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1995 Jul; 46(3):230-7. PubMed ID: 7561795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum hepatitis C virus levels in patients with chronic hepatitis C treated with two courses of interferon administration.
    Saitoh Y; Miura M; Niitsuma H; Numata N; Ohori H; Ishii M; Toyota T
    Tohoku J Exp Med; 1994 Aug; 173(4):361-9. PubMed ID: 7529950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates.
    Garson JA; Tuke PW; Makris M; Briggs M; Machin SJ; Preston FE; Tedder RS
    Lancet; 1990 Oct; 336(8722):1022-5. PubMed ID: 1977017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retreatment of chronic hepatitis C with interferon.
    Toyoda H; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Suga T; Ohki H; Ito O
    Am J Gastroenterol; 1994 Sep; 89(9):1453-7. PubMed ID: 7521572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response.
    Donadel E; Pontisso P; Ruvoletto MG; Gerotto M; De Salvo G; Chemello L; Casarin C; Alberti A
    J Med Virol; 1998 Jan; 54(1):7-11. PubMed ID: 9443103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.